Scandinavia: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in Scandinavia

The Scandinavia medicaments containing insulin market amounted to $X in 2023, growing by X% against the previous year. In general, consumption recorded a slight descent. The level of consumption peaked at $X in 2013; however, from 2014 to 2023, consumption failed to regain momentum.

Medicaments Containing Insulin Production in Scandinavia

In value terms, medicaments containing insulin production amounted to $X in 2023 estimated in export price. Over the period under review, production, however, continues to indicate a relatively flat trend pattern. The most prominent rate of growth was recorded in 2013 when the production volume increased by X%. As a result, production attained the peak level of $X. From 2014 to 2023, production growth remained at a somewhat lower figure.

Medicaments Containing Insulin Exports

Exports in Scandinavia

In 2023, shipments abroad of medicaments containing insulin but not antibiotics increased by X% to X kg for the first time since 2020, thus ending a two-year declining trend. Over the period under review, exports, however, recorded a abrupt contraction. The most prominent rate of growth was recorded in 2020 with an increase of X% against the previous year. The volume of export peaked at X tons in 2014; however, from 2015 to 2023, the exports failed to regain momentum.

In value terms, medicaments containing insulin exports surged to $X in 2023. Overall, exports showed perceptible growth. The growth pace was the most rapid in 2020 with an increase of X% against the previous year. The level of export peaked at $X in 2014; however, from 2015 to 2023, the exports failed to regain momentum.

Exports by Country

Sweden was the major exporter of medicaments containing insulin but not antibiotics in Scandinavia, with the volume of exports reaching X kg, which was approx. X% of total exports in 2023. It was distantly followed by Finland (X kg), comprising an X% share of total exports.

From 2013 to 2023, average annual rates of growth with regard to medicaments containing insulin exports from Sweden stood at X%. Finland experienced a relatively flat trend pattern. From 2013 to 2023, the share of Finland increased by X percentage points.

In value terms, Sweden ($X) remains the largest medicaments containing insulin supplier in Scandinavia, comprising X% of total exports. The second position in the ranking was taken by Finland ($X), with a X% share of total exports.

From 2013 to 2023, the average annual growth rate of value in Sweden stood at X%.

Export Prices by Country

In 2023, the export price in Scandinavia amounted to $X per ton, declining by X% against the previous year. Overall, the export price, however, continues to indicate buoyant growth. The most prominent rate of growth was recorded in 2020 when the export price increased by X% against the previous year. Over the period under review, the export prices reached the maximum at $X per ton in 2021; however, from 2022 to 2023, the export prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Sweden ($X per ton), while Finland stood at $X per ton.

From 2013 to 2023, the most notable rate of growth in terms of prices was attained by Sweden (X%).

Medicaments Containing Insulin Imports

Imports in Scandinavia

In 2023, supplies from abroad of medicaments containing insulin but not antibiotics decreased by X% to X kg for the first time since 2018, thus ending a four-year rising trend. Overall, imports continue to indicate a precipitous slump. The most prominent rate of growth was recorded in 2016 with an increase of X% against the previous year. Over the period under review, imports attained the peak figure at X tons in 2012; however, from 2013 to 2023, imports failed to regain momentum.

In value terms, medicaments containing insulin imports surged to $X in 2023. In general, imports saw a deep downturn. The growth pace was the most rapid in 2016 with an increase of X%. The level of import peaked at $X in 2013; however, from 2014 to 2023, imports failed to regain momentum.

Imports by Country

Norway dominates imports structure, resulting at X kg, which was near X% of total imports in 2023. The following importers - Finland (X kg) and Sweden (X kg) - each accounted for a X% share of total imports.

From 2012 to 2023, average annual rates of growth with regard to medicaments containing insulin imports into Norway stood at X%. Finland experienced a relatively flat trend pattern. Sweden (X%) illustrated a downward trend over the same period. Sweden (X p.p.) and Finland (X p.p.) significantly strengthened its position in terms of the total imports, while Norway saw its share reduced by X% from 2012 to 2023, respectively.

In value terms, Norway ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in Scandinavia, comprising X% of total imports. The second position in the ranking was held by Finland ($X), with less than X% share of total imports.

From 2012 to 2023, the average annual growth rate of value in Norway totaled X%. The remaining importing countries recorded the following average annual rates of imports growth: Finland (X% per year) and Sweden (X% per year).

Import Prices by Country

In 2023, the import price in Scandinavia amounted to $X per kg, increasing by X% against the previous year. Overall, the import price enjoyed significant growth. The pace of growth was the most pronounced in 2013 when the import price increased by X%. Over the period under review, import prices reached the peak figure at $X per kg in 2021; however, from 2022 to 2023, import prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Norway ($X per kg), while Sweden ($X per kg) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Norway (X%), while the other leaders experienced a decline in the import price figures.

Source: IndexBox Platform